NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.0760
+0.0160 (26.67%)
Jan 9, 2026, 4:00 PM EST - Market closed
26.67%
Market Cap65.72M
Revenue (ttm)242,000
Net Income (ttm)-38.06M
Shares Out 28.10M
EPS (ttm)-2.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,384
Open0.0600
Previous Close0.0600
Day's Range0.0578 - 0.0760
52-Week Range0.0401 - 0.3900
Beta1.62
Analystsn/a
Price Targetn/a
Earnings DateNov 17, 2025

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

News

There is no news available yet.